Variant report
Variant | nsv970619 |
---|---|
Chromosome Location | chr7:153655790-153731030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:162)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr7:153686171-153686487 | GM12878 | blood: | n/a | n/a |
2 | BCL3 | chr7:153686222-153686486 | GM12878 | blood: | n/a | n/a |
3 | BHLHE40 | chr7:153671731-153672005 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr7:153708400-153708682 | K562 | blood: | n/a | chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708507-153708518 chr7:153708509-153708518 |
5 | CEBPB | chr7:153708406-153708655 | A549 | lung: | n/a | chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708507-153708518 chr7:153708509-153708518 |
6 | CEBPB | chr7:153661713-153661899 | HepG2 | liver: | n/a | n/a |
7 | CEBPB | chr7:153703491-153703685 | HepG2 | liver: | n/a | chr7:153703626-153703637 chr7:153703628-153703637 |
8 | CEBPB | chr7:153708328-153708611 | HepG2 | liver: | n/a | chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708509-153708518 chr7:153708507-153708518 chr7:153708509-153708518 |
9 | CEBPB | chr7:153671722-153671982 | HepG2 | liver: | n/a | n/a |
10 | CTCF | chr7:153687068-153687129 | GM19240 | blood: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
11 | CTCF | chr7:153686920-153687070 | K562 | blood: | n/a | n/a |
12 | CTCF | chr7:153687687-153687787 | Fibrobl | skin: | n/a | n/a |
13 | CTCF | chr7:153712751-153712835 | HepG2 | liver: | n/a | n/a |
14 | CTCF | chr7:153727930-153727991 | Medullo | brain: | n/a | n/a |
15 | CTCF | chr7:153713944-153713981 | Medullo | brain: | n/a | n/a |
16 | CTCF | chr7:153686988-153687201 | Hela-S3 | cervix: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
17 | CTCF | chr7:153712698-153713112 | K562 | blood: | n/a | n/a |
18 | CTCF | chr7:153687023-153687199 | LNCaP | prostate: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
19 | CTCF | chr7:153712960-153713110 | SK-N-SH_RA | brain: | n/a | n/a |
20 | CTCF | chr7:153694274-153694339 | Fibrobl | skin: | n/a | n/a |
21 | CTCF | chr7:153686986-153687207 | H1-hESC | embryonic stem cell: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
22 | CTCF | chr7:153687030-153687193 | MCF-7 | breast: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
23 | CTCF | chr7:153687074-153687156 | GM19238 | blood: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
24 | CTCF | chr7:153687044-153687151 | GM19239 | blood: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
25 | CTCF | chr7:153687082-153687112 | A549 | lung: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
26 | CTCF | chr7:153687128-153687145 | GM12878 | blood: | n/a | n/a |
27 | CTCF | chr7:153712420-153712500 | LNCaP | prostate: | n/a | n/a |
28 | CTCF | chr7:153705011-153705076 | ProgFib | skin: | n/a | n/a |
29 | CTCF | chr7:153712735-153713193 | K562 | blood: | n/a | n/a |
30 | CTCF | chr7:153712600-153712750 | BE2_C | brain: | n/a | n/a |
31 | CTCF | chr7:153712842-153712867 | HepG2 | liver: | n/a | n/a |
32 | CTCF | chr7:153686897-153687389 | K562 | blood: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
33 | CTCF | chr7:153687030-153687153 | GM12891 | blood: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
34 | CTCF | chr7:153659757-153659816 | LNCaP | prostate: | n/a | n/a |
35 | CTCF | chr7:153712900-153713050 | SK-N-SH_RA | brain: | n/a | n/a |
36 | CTCF | chr7:153712680-153712830 | K562 | blood: | n/a | n/a |
37 | CTCF | chr7:153712731-153712909 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | CTCF | chr7:153687030-153687158 | Gliobla | brain: | n/a | chr7:153687095-153687108 chr7:153687093-153687111 |
39 | CTCF | chr7:153712940-153713090 | HEK293 | kidney: | n/a | n/a |
40 | CTCF | chr7:153657784-153657790 | GM19239 | blood: | n/a | n/a |
41 | CTCF | chr7:153712920-153713070 | NB4 | blood: | n/a | n/a |
42 | CTCF | chr7:153712910-153713130 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | CTCF | chr7:153712738-153713158 | K562 | blood: | n/a | n/a |
44 | CTCF | chr7:153712810-153712878 | ProgFib | skin: | n/a | n/a |
45 | CTCF | chr7:153687123-153687127 | GM12878 | blood: | n/a | n/a |
46 | CTCF | chr7:153686955-153687240 | K562 | blood: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
47 | CTCF | chr7:153656565-153656620 | Medullo | brain: | n/a | n/a |
48 | CTCF | chr7:153672056-153672078 | GM20000 | blood: | n/a | n/a |
49 | CTCF | chr7:153686950-153687195 | MCF-7 | breast: | n/a | chr7:153687148-153687161 chr7:153687149-153687159 chr7:153687141-153687162 chr7:153687095-153687108 chr7:153687146-153687164 chr7:153687152-153687161 chr7:153687093-153687111 |
50 | CTCF | chr7:153710860-153710912 | Kidney_OC | kidney: | n/a | n/a |
No data |
No data |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PAXIP1-3 | chr7:153724009-153724133 | ENSG00000203335.3 |
2 | lnc-PAXIP1-3 | chr7:153723372-153723775 | ENSG00000203335.3 |
3 | lnc-PAXIP1-3 | chr7:153724009-153724131 | ENSG00000203335.3 |
4 | lnc-PAXIP1-3 | chr7:153723665-153723775 | ENSG00000203335.3 |
5 | lnc-PAXIP1-3 | chr7:153721094-153721199 | ENSG00000203335.3 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000226509 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370321637 | chr7:153655799-153655800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2190996 | chr7:153655835-153655836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527382146 | chr7:153655839-153655840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548612301 | chr7:153655868-153655869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566911732 | chr7:153655874-153655875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537405741 | chr7:153655881-153655882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549665274 | chr7:153655886-153655887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571423447 | chr7:153655913-153655914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs137984820 | chr7:153656017-153656018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553669163 | chr7:153656023-153656024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572530428 | chr7:153656036-153656037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377082572 | chr7:153656109-153656110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555044335 | chr7:153656165-153656166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576516165 | chr7:153656177-153656178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543792956 | chr7:153656199-153656200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374049079 | chr7:153656200-153656201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573931433 | chr7:153668893-153668894 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs544588260 | chr7:153668908-153668909 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs144300623 | chr7:153669475-153669476 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs541527812 | chr7:153671807-153671808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559558520 | chr7:153671819-153671820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530132449 | chr7:153671820-153671821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148083346 | chr7:153671843-153671844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10236251 | chr7:153671870-153671871 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs531106592 | chr7:153671879-153671880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370708258 | chr7:153671884-153671885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570727753 | chr7:153671907-153671908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186004804 | chr7:153671911-153671912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs39150 | chr7:153671940-153671941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565623768 | chr7:153671943-153671944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374120806 | chr7:153671957-153671958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554604119 | chr7:153671977-153671978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555747600 | chr7:153672035-153672036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537354650 | chr7:153672044-153672045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs39149 | chr7:153672048-153672049 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs191166017 | chr7:153672054-153672055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540844029 | chr7:153672146-153672147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559829853 | chr7:153672161-153672162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574827162 | chr7:153672163-153672164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78694955 | chr7:153672172-153672173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114015370 | chr7:153672188-153672189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569260096 | chr7:153685602-153685603 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116511594 | chr7:153685624-153685625 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199601665 | chr7:153685635-153685636 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540818121 | chr7:153685636-153685637 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553148631 | chr7:153685688-153685689 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2907723 | chr7:153685698-153685699 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574481369 | chr7:153685701-153685702 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541522207 | chr7:153685728-153685729 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563312730 | chr7:153685737-153685738 | Bivalent Enhancer Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Autism | 20808228 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lobular carcinoma | 20920651 | CNVD |
Long-qt syndrome | 20920651 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Nasopharyngeal cancer | 20548289 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 22495309 | CNVD |
Chordoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:153654600-153655800 | Enhancers | Brain Inferior Temporal Lobe | brain |
2 | chr7:153654600-153656200 | Enhancers | Brain Hippocampus Middle | brain |
3 | chr7:153655400-153656000 | Enhancers | Brain Substantia Nigra | brain |
4 | chr7:153671800-153672200 | Enhancers | HepG2 | liver |
5 | chr7:153685600-153685800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
6 | chr7:153685600-153685800 | Flanking Bivalent TSS/Enh | Fetal Muscle Trunk | muscle |
7 | chr7:153686800-153687000 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:153702200-153705200 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr7:153705200-153708000 | Weak transcription | Fetal Muscle Leg | muscle |
10 | chr7:153706600-153708800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr7:153708000-153708600 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr7:153708200-153708600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr7:153708400-153708600 | Enhancers | Psoas Muscle | Psoas |
14 | chr7:153708600-153711000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
15 | chr7:153708600-153717800 | Weak transcription | Fetal Muscle Leg | muscle |
16 | chr7:153708800-153710000 | Weak transcription | Psoas Muscle | Psoas |
17 | chr7:153710000-153710400 | Enhancers | Psoas Muscle | Psoas |
18 | chr7:153711000-153711200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
19 | chr7:153717800-153718600 | Enhancers | Fetal Muscle Leg | muscle |
20 | chr7:153718600-153719600 | Weak transcription | Fetal Muscle Leg | muscle |
21 | chr7:153719600-153719800 | Enhancers | Fetal Muscle Leg | muscle |
22 | chr7:153719800-153727000 | Weak transcription | Fetal Muscle Leg | muscle |
23 | chr7:153723600-153723800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
24 | chr7:153723800-153725000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
25 | chr7:153725000-153725400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
26 | chr7:153726400-153727600 | Enhancers | Fetal Muscle Trunk | muscle |
27 | chr7:153727000-153729200 | Enhancers | Fetal Muscle Leg | muscle |